GlassScriptPhysician profile
Neal Agee
NPI 1295005395
$3,868.75
in general payments reported to CMS, 2019-2025
30 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $385 · 2021: $1,462 · 2022: $590 · 2023: $159 · 2024: $106 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $561.99 | 2020-2021 | |
| Amgen INC. | $554.41 | 2019-2022 | |
| Ethicon US, LLC | $373.29 | 2019-2023 | Harmonic |
| Intuitive Surgical, INC. | $354.91 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $270.73 | 2019-2024 | |
| Nestle Healthcare Nutrition INC. | $266.04 | 2021-2022 | |
| Novo Nordisk INC | $243.21 | 2020-2021 | |
| Boston Scientific Corporation | $175.84 | 2021-2022 | |
| Kci USA, INC. | $132.11 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.35 | 2021 | |
| Bard Peripheral Vascular, INC. | $118.85 | 2020-2021 | |
| Tela Bio, INC. | $102.38 | 2019 | |
| Medical Device Business Services, INC. | $95.88 | 2022 | |
| Sanara Medtech INC. | $81.30 | 2021-2022 | |
| Davol INC. | $58.38 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $50.57 | 2022-2023 | Puraply |
| Merck Sharp & Dohme LLC | $43.63 | 2022 | |
| Covidien LP | $37.05 | 2019 | |
| Integra Lifesciences Corporation | $28.38 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $27.07 | 2022 | |
| Smith+Nephew, INC. | $24.51 | 2024 | Grafix Pl |
| Tei Biosciences INC | $20.50 | 2019 | |
| Medtronic, INC. | $18.89 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.10 | 2021 | |
| Kerecis Limited | $17.18 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Myriad Genetic Laboratories, INC. | $15.73 | 2023 | Myrisk |
| Blueprint Medicines Corporation | $15.02 | 2024 | Ayvakit |
| W. L. Gore & Associates, INC. | $14.90 | 2019 | |
| Shire North American Group INC | $13.79 | 2019 | |
| Asensus Surgical, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Agee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.